Florian Wolfgang Kiefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Florian Wolfgang Kiefer has a total of 291 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Michael Stulnig
Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria
13 shared publications - Alexandra Kautzky-Willer
Division of Endocrinology and Metabolism, Department of Medicine III Medical University of Vienna Vienna Austria
10 shared publications - Maximilian Zeyda
Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, 1090 Vienna, Austria
10 shared publications Gerhard Prager
Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna , Vienna
8 shared publicationsAnna Fenzl
7 shared publications- Carsten Thilo Herz
Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
7 shared publications
Latest Publications
- Open Access
Stress-induced Metabolic Remodeling of Adipose and Brain Tissue Revealed by Positron Emission Tomography
Stress impacts our health and triggers physiological adaptations, yet the metabolic programs engaged during stress remain incompletely understood. To fill this knowledge gap, we utilize total-body positron emission tomography (PET), multi-OMICS, and endocrine profiling to assess how various murine stress models affect systemic metabolic remodeling. We find that acute immobilization and surgery activate brown adipose tissue as part of the stress response, independently of hypothermia, thereby acting as a highly stress-sensitive metabolic hub. Additionally, we identify stress-specific hypo- and hypermetabolic signatures in different brain regions, and distinguish networks between brain and adipose tissue depots across the different stress groups. Our work presents a novel perspective on stress and its mobilization of metabolic resources and identifies PET imaging of brain and adipose tissue as a valuable, minimally invasive technique for tracking metabolic stress responses in mice, with relevance for animal welfare and disease models, and translational impact for mental health studies and preventive medicine.
Open AccessStress-induced Metabolic Remodeling of Adipose and Brain Tissue Revealed by Positron Emission Tomography
Stress impacts our health and triggers physiological adaptations, yet the metabolic programs engaged during stress remain incompletely understood. To fill this knowledge gap, we utilize total-body positron emission tomography (PET), multi-OMICS, and endocrine profiling to assess how various murine stress models affect systemic metabolic remodeling. We find that acute immobilization and surgery activate brown adipose tissue as part of the stress response, independently of hypothermia, thereby acting as a highly stress-sensitive metabolic hub. Additionally, we identify stress-specific hypo- and hypermetabolic signatures in different brain regions, and distinguish networks between brain and adipose tissue depots across the different stress groups. Our work presents a novel perspective on stress and its mobilization of metabolic resources and identifies PET imaging of brain and adipose tissue as a valuable, minimally invasive technique for tracking metabolic stress responses in mice, with relevance for animal welfare and disease models, and translational impact for mental health studies and preventive medicine.
- 1 July 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (7)
Active Brown Adipose Tissue Is Associated With Reduced Arterial Inflammation and Less Atherogenic Circulating Factors in Individuals With Obesity
BACKGROUND: Increasing evidence from preclinical models has linked the actions of brown adipose tissue (BAT) with protection against atherosclerosis and cardiovascular disease, in part due to its salutary effects on systemic lipid composition. However, human data on the role of BAT in atherosclerosis are scarce. METHODS: In this cross-sectional study, we examined 65 individuals with obesity and analyzed cold-induced BAT activity and vascular inflammation in the aorta using 18 F-fluorodeoxyglucose positron emission tomography combined with computed tomography in combination with systemic lipidomics and proteomics analyses. RESULTS: We identified 21 subjects with cold-induced BAT (BAT positive), whereas 44 individuals had no significant BAT activity (BAT negative) after cold exposure. Both groups had similar age, sex distribution, body mass index, and classical cardiovascular risk profile. However, BAT-positive individuals had significantly less arterial inflammation as evidenced by lower 18 F-fluorodeoxyglucose uptake in the ascending aorta and the aortic arch. Notably, BAT volume, SUV mean (mean standardized uptake value), and cold-induced thermogenesis correlated negatively with aortic inflammation, suggesting an atheroprotective role of BAT. Using unbiased lipidomics and proteomics analyses in plasma, we found that anti-inflammatory and potentially antiatherogenic circulating factors, such as cytochrome P450 oxylipin products and the serpin family member SERPINB12 (serpin family B member 12), were increased in BAT positive, whereas proatherogenic and prothrombotic factors, including acute phase protein ORM2 (orosomucoid 2), APOD (apolipoprotein D), FGA (fibrinogen A), and FGB (fibrinogen B), were significantly lower in individuals with active BAT. Likewise, the circulating concentrations of inflammatory markers, such as IL-6 (interleukin-6), were reduced in BAT positive versus BAT negative. CONCLUSIONS: Together, these data link human BAT function with protection against arterial inflammation and a potentially antiatherogenic and anti-inflammatory circulating profile. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT02381483 and NCT03168009.
- 1 July 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (7)
Active Brown Adipose Tissue Is Associated With Reduced Arterial Inflammation and Less Atherogenic Circulating Factors in Individuals With Obesity
BACKGROUND: Increasing evidence from preclinical models has linked the actions of brown adipose tissue (BAT) with protection against atherosclerosis and cardiovascular disease, in part due to its salutary effects on systemic lipid composition. However, human data on the role of BAT in atherosclerosis are scarce. METHODS: In this cross-sectional study, we examined 65 individuals with obesity and analyzed cold-induced BAT activity and vascular inflammation in the aorta using 18 F-fluorodeoxyglucose positron emission tomography combined with computed tomography in combination with systemic lipidomics and proteomics analyses. RESULTS: We identified 21 subjects with cold-induced BAT (BAT positive), whereas 44 individuals had no significant BAT activity (BAT negative) after cold exposure. Both groups had similar age, sex distribution, body mass index, and classical cardiovascular risk profile. However, BAT-positive individuals had significantly less arterial inflammation as evidenced by lower 18 F-fluorodeoxyglucose uptake in the ascending aorta and the aortic arch. Notably, BAT volume, SUV mean (mean standardized uptake value), and cold-induced thermogenesis correlated negatively with aortic inflammation, suggesting an atheroprotective role of BAT. Using unbiased lipidomics and proteomics analyses in plasma, we found that anti-inflammatory and potentially antiatherogenic circulating factors, such as cytochrome P450 oxylipin products and the serpin family member SERPINB12 (serpin family B member 12), were increased in BAT positive, whereas proatherogenic and prothrombotic factors, including acute phase protein ORM2 (orosomucoid 2), APOD (apolipoprotein D), FGA (fibrinogen A), and FGB (fibrinogen B), were significantly lower in individuals with active BAT. Likewise, the circulating concentrations of inflammatory markers, such as IL-6 (interleukin-6), were reduced in BAT positive versus BAT negative. CONCLUSIONS: Together, these data link human BAT function with protection against arterial inflammation and a potentially antiatherogenic and anti-inflammatory circulating profile. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT02381483 and NCT03168009.
- Open Access
- 10 October 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (1) , 106-112
N-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women
- 10 October 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (1) , 106-112
Open AccessN-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women
- Open Access
- 30 April 2025
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 192 (5) , 603-613
Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota
Objective: The mechanisms of bariatric surgery-induced weight loss and metabolic improvements are still incompletely understood and reach beyond malabsorption or calorie restriction. We sought to investigate the effect of bariatric surgery on brown adipose tissue (BAT) activity and a potential connection with changes in energy metabolism, the gut microbiota, and short-chain fatty acid (SCFA) composition. Methods: We included 32 subjects (25 females) with morbid obesity and analyzed their metabolic profile, gut microbiota composition, circulating SCFAs, energy expenditure, and cold-induced BAT activity using [18F]Fluorodeoxyglucose-positron emission tomography–computed tomography before and up to 1 year after bariatric surgery. Results: Twelve months after surgery, the percentage of individuals with active BAT had increased from 28% to 53%. The BAT-negative (BATneg) individuals who had an adverse metabolic profile at baseline compared with subjects with active BAT (BATpos) showed a greater metabolic benefit after surgery. While no changes in overall gut bacterial diversity were observed between BATpos and BATneg, the abundance of 3 specific bacterial families, including Akkermansiaceae, Pasteurellaceae, and Carnobacteriaceae, was distinctly regulated between BAT groups. The bacterial genera most strongly increased in BATpos vs BATneg subjects were all positively correlated with BAT volume and BAT activity. Finally, circulating concentrations of the SCFAs acetate, butyrate, and propionate rose after bariatric surgery and were related to bacterial genera such as Akkermansia, Dialister, and Lachnospiraceae FCS020 group, all known SCFA producers. Conclusions: Bariatric surgery helps recruit active BAT in individuals with obesity and is linked to distinct alterations in the gut microbiome and SCFA composition. Trial registration number: ClinicalTrials.gov (NCT03168009).
- 30 April 2025
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 192 (5) , 603-613
Open AccessBariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota
Objective: The mechanisms of bariatric surgery-induced weight loss and metabolic improvements are still incompletely understood and reach beyond malabsorption or calorie restriction. We sought to investigate the effect of bariatric surgery on brown adipose tissue (BAT) activity and a potential connection with changes in energy metabolism, the gut microbiota, and short-chain fatty acid (SCFA) composition. Methods: We included 32 subjects (25 females) with morbid obesity and analyzed their metabolic profile, gut microbiota composition, circulating SCFAs, energy expenditure, and cold-induced BAT activity using [18F]Fluorodeoxyglucose-positron emission tomography–computed tomography before and up to 1 year after bariatric surgery. Results: Twelve months after surgery, the percentage of individuals with active BAT had increased from 28% to 53%. The BAT-negative (BATneg) individuals who had an adverse metabolic profile at baseline compared with subjects with active BAT (BATpos) showed a greater metabolic benefit after surgery. While no changes in overall gut bacterial diversity were observed between BATpos and BATneg, the abundance of 3 specific bacterial families, including Akkermansiaceae, Pasteurellaceae, and Carnobacteriaceae, was distinctly regulated between BAT groups. The bacterial genera most strongly increased in BATpos vs BATneg subjects were all positively correlated with BAT volume and BAT activity. Finally, circulating concentrations of the SCFAs acetate, butyrate, and propionate rose after bariatric surgery and were related to bacterial genera such as Akkermansia, Dialister, and Lachnospiraceae FCS020 group, all known SCFA producers. Conclusions: Bariatric surgery helps recruit active BAT in individuals with obesity and is linked to distinct alterations in the gut microbiome and SCFA composition. Trial registration number: ClinicalTrials.gov (NCT03168009).
- Open Access
- 19 March 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (3) , e261704
Postpartum pheochromocytoma crisis associated with cardiogenic shock and Sheehan’s syndrome
We report a case of a woman in her mid-30s who developed severe cardiac shock hours after giving birth to her second child with the need for extracorporeal haemodynamic support. Initially, postpartum cardiomyopathy was suspected, and high-urgency heart transplantation was considered. However, the endocrine work-up and imaging revealed pheochromocytoma as the cause for acute heart failure that was completely reversible. Notably, the patient also developed Sheehan’s syndrome with pituitary necrosis and sustained hypopituitarism, most likely as a consequence of the haemodynamic failure during pheochromocytoma crisis. While pheochromocytoma crisis is already an extremely rare peripartum complication, the current case is—to the best of our knowledge—the first report of pheochromocytoma associated with Sheehan’s syndrome. This case also highlights the clinical conundrum that pheochromocytomas can be easily overlooked in pregnancy due to non-specific symptoms and confusion with pregnancy-related hypertension or hypertension-associated other diseases. Appropriate case detection is important, especially in pregnant women with early onset of hypertension.
- 19 March 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (3) , e261704
Open AccessPostpartum pheochromocytoma crisis associated with cardiogenic shock and Sheehan’s syndrome
We report a case of a woman in her mid-30s who developed severe cardiac shock hours after giving birth to her second child with the need for extracorporeal haemodynamic support. Initially, postpartum cardiomyopathy was suspected, and high-urgency heart transplantation was considered. However, the endocrine work-up and imaging revealed pheochromocytoma as the cause for acute heart failure that was completely reversible. Notably, the patient also developed Sheehan’s syndrome with pituitary necrosis and sustained hypopituitarism, most likely as a consequence of the haemodynamic failure during pheochromocytoma crisis. While pheochromocytoma crisis is already an extremely rare peripartum complication, the current case is—to the best of our knowledge—the first report of pheochromocytoma associated with Sheehan’s syndrome. This case also highlights the clinical conundrum that pheochromocytomas can be easily overlooked in pregnancy due to non-specific symptoms and confusion with pregnancy-related hypertension or hypertension-associated other diseases. Appropriate case detection is important, especially in pregnant women with early onset of hypertension.
- Open Access
- 11 October 2023
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 135 (S6) , 743-750
Prävention und Management von postinterventioneller Gewichtszunahme
Zusammenfassung: Die Ursachen der postinterventionellen Gewichtszunahme nach Lebensstiländerung, psychologischer Therapie, Pharmakotherapie oder chirurgischen Maßnahmen gehen weit über einen Motivations- oder Compliance-Verlust der Betroffenen hinaus. Der Gewichtszunahme liegen komplexe periphere und zentrale Mechanismen zugrunde, deren Ausmaß individuell unterschiedlich zu sein scheint und die darauf ausgerichtet sind, die Nahrungszufuhr durch reduziertes Sättigungs- und vermehrtes Hungergefühl zu erhöhen (gastrointestinale Hormone) und den Energieverbrauch zu reduzieren (metabolische Adaptierung). Diese Mechanismen erschweren das Abnehmen und Gewichthalten in einem „adipogenen“ Lebensraum, wie wir in weltweit immer häufiger vorfinden, ungemein. Das Verständnis dieser molekularen Mechanismen sollte in die Planung von Therapieprogrammen zur langfristigen Gewichtsreduktion, welche eine entsprechende Nachsorge zur Prävention und individualisierten Therapie einer postinterventionellen Gewichtszunahme beinhalten sollten, miteinbezogen werden. Dabei empfiehlt es sich, die therapeutischen Maßnahmen und Kontrollintervalle nach dem Ausmaß der Gewichtszunahme pro Zeitintervall auszurichten.
- 11 October 2023
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 135 (S6) , 743-750
Open AccessPrävention und Management von postinterventioneller Gewichtszunahme
Zusammenfassung: Die Ursachen der postinterventionellen Gewichtszunahme nach Lebensstiländerung, psychologischer Therapie, Pharmakotherapie oder chirurgischen Maßnahmen gehen weit über einen Motivations- oder Compliance-Verlust der Betroffenen hinaus. Der Gewichtszunahme liegen komplexe periphere und zentrale Mechanismen zugrunde, deren Ausmaß individuell unterschiedlich zu sein scheint und die darauf ausgerichtet sind, die Nahrungszufuhr durch reduziertes Sättigungs- und vermehrtes Hungergefühl zu erhöhen (gastrointestinale Hormone) und den Energieverbrauch zu reduzieren (metabolische Adaptierung). Diese Mechanismen erschweren das Abnehmen und Gewichthalten in einem „adipogenen“ Lebensraum, wie wir in weltweit immer häufiger vorfinden, ungemein. Das Verständnis dieser molekularen Mechanismen sollte in die Planung von Therapieprogrammen zur langfristigen Gewichtsreduktion, welche eine entsprechende Nachsorge zur Prävention und individualisierten Therapie einer postinterventionellen Gewichtszunahme beinhalten sollten, miteinbezogen werden. Dabei empfiehlt es sich, die therapeutischen Maßnahmen und Kontrollintervalle nach dem Ausmaß der Gewichtszunahme pro Zeitintervall auszurichten.
- 3 April 2023
- Published by JSTOR
- p. 7-24
Interdisziplinäre Zugänge zu digitalen Spielen und ihrer sozialen und kulturellen Bedeutung – Einführung der Herausgeber
- 3 April 2023
- Published by JSTOR
- p. 7-24
Interdisziplinäre Zugänge zu digitalen Spielen und ihrer sozialen und kulturellen Bedeutung – Einführung der Herausgeber
- Open Access
- 31 March 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 858417
Brown Adipose Tissue Prevalence Is Lower in Obesity but Its Metabolic Activity Is Intact
Due to its high metabolic activity, brown adipose tissue (BAT) has become a promising target for the development of novel treatment concepts for metabolic disease. Despite several reports of a negative association between the presence of active BAT and obesity, very little is known about the quantitative and qualitative differences of BAT in lean and obese individuals. Systematic studies directly comparing cold-induced BAT activity in leanness and obesity are currently lacking. Here we studied BAT mass and function in 31 lean and 64 obese men and women. After a standardized cooling protocol using a water-perfused vest, 18F-FDG-positron emission tomography/computed tomography scans were performed, and BAT was delineated using lean body-mass adjusted standardized uptake value (SUV) thresholds in anatomic regions with fat radiodensity. Cold-induced thermogenesis (CIT), a functional readout of BAT activity, was quantified by indirect calorimetry. Active BAT was present in a significantly higher proportion of lean than obese individuals (58% vs. 33%, p=0.019). In these participants with active BAT, however, BAT volume and activity did not differ between leanness and obesity. Accordingly, CIT was similar in both weight groups. BAT metrics were not related to adiposity or total fat mass per se. However, in obese participants a strong negative correlation existed between visceral adipose tissue and BAT volume, 18F-FDG uptake and CIT. In summary, despite a significantly lower prevalence of BAT, the metabolic activity and thermogenic capacity of BAT appears to be still intact in obesity and is inversely associated with visceral fat mass.
- 31 March 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 858417
Open AccessBrown Adipose Tissue Prevalence Is Lower in Obesity but Its Metabolic Activity Is Intact
Due to its high metabolic activity, brown adipose tissue (BAT) has become a promising target for the development of novel treatment concepts for metabolic disease. Despite several reports of a negative association between the presence of active BAT and obesity, very little is known about the quantitative and qualitative differences of BAT in lean and obese individuals. Systematic studies directly comparing cold-induced BAT activity in leanness and obesity are currently lacking. Here we studied BAT mass and function in 31 lean and 64 obese men and women. After a standardized cooling protocol using a water-perfused vest, 18F-FDG-positron emission tomography/computed tomography scans were performed, and BAT was delineated using lean body-mass adjusted standardized uptake value (SUV) thresholds in anatomic regions with fat radiodensity. Cold-induced thermogenesis (CIT), a functional readout of BAT activity, was quantified by indirect calorimetry. Active BAT was present in a significantly higher proportion of lean than obese individuals (58% vs. 33%, p=0.019). In these participants with active BAT, however, BAT volume and activity did not differ between leanness and obesity. Accordingly, CIT was similar in both weight groups. BAT metrics were not related to adiposity or total fat mass per se. However, in obese participants a strong negative correlation existed between visceral adipose tissue and BAT volume, 18F-FDG uptake and CIT. In summary, despite a significantly lower prevalence of BAT, the metabolic activity and thermogenic capacity of BAT appears to be still intact in obesity and is inversely associated with visceral fat mass.
- 18 October 2021
- Published by American Diabetes Association in Diabetes
- Vol. 71 (1) , 93-103
Active Brown Adipose Tissue Is Associated With a Healthier Metabolic Phenotype in Obesity
Obesity is associated with increasing cardiometabolic morbidity and mortality worldwide. Not everyone with obesity, however, develops metabolic complications. Brown adipose tissue (BAT) has been suggested as a promoter of leanness and metabolic health. To date, little is known about the prevalence and metabolic function of BAT in subjects with severe obesity, a population at high cardiometabolic risk. In this cross-sectional study, we included 40 individuals with WHO class II-III obesity (BMI ≥ 35 kg/m2). Employing a 150-minute personalized cooling protocol and 18F-fluorodeoxyglucose positron emission tomography/computed tomography, cold-activated BAT was detectable in 14 (35%) of the participants. Cold-induced thermogenesis was significantly higher in participants with detectable BAT compared to those without. Notably, individuals with obesity and active BAT had 28.8% lower visceral fat mass despite slightly higher total fat mass compared to those without detectable BAT 18F-FDG uptake. This was accompanied by lower insulin resistance and systemic inflammation and improved NAFLD parameters, all adjusted for age, sex, and percent body fat. Contrary to previous assumptions, we show here that a significant fraction of individuals with severe obesity has active BAT. We found that decreased BAT 18F-FDG uptake was not associated with adiposity per se but with higher visceral fat mass. In summary, active BAT is linked to a healthier metabolic phenotype in obesity.
- 18 October 2021
- Published by American Diabetes Association in Diabetes
- Vol. 71 (1) , 93-103
Active Brown Adipose Tissue Is Associated With a Healthier Metabolic Phenotype in Obesity
Obesity is associated with increasing cardiometabolic morbidity and mortality worldwide. Not everyone with obesity, however, develops metabolic complications. Brown adipose tissue (BAT) has been suggested as a promoter of leanness and metabolic health. To date, little is known about the prevalence and metabolic function of BAT in subjects with severe obesity, a population at high cardiometabolic risk. In this cross-sectional study, we included 40 individuals with WHO class II-III obesity (BMI ≥ 35 kg/m2). Employing a 150-minute personalized cooling protocol and 18F-fluorodeoxyglucose positron emission tomography/computed tomography, cold-activated BAT was detectable in 14 (35%) of the participants. Cold-induced thermogenesis was significantly higher in participants with detectable BAT compared to those without. Notably, individuals with obesity and active BAT had 28.8% lower visceral fat mass despite slightly higher total fat mass compared to those without detectable BAT 18F-FDG uptake. This was accompanied by lower insulin resistance and systemic inflammation and improved NAFLD parameters, all adjusted for age, sex, and percent body fat. Contrary to previous assumptions, we show here that a significant fraction of individuals with severe obesity has active BAT. We found that decreased BAT 18F-FDG uptake was not associated with adiposity per se but with higher visceral fat mass. In summary, active BAT is linked to a healthier metabolic phenotype in obesity.
- 1 October 2021
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 536, 111403
Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue
- 1 October 2021
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 536, 111403
Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue